Evidence map›Paper›PMID 32016346›Full record

ArticleThe Journal of antimicrobial chemotherapy2020

A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?

Eilidh M Duncan, Esmita Charani, Janet E Clarkson, Jill J Francis, Katie Gillies, Jeremy M Grimshaw, Winfried V Kern, Fabiana Lorencatto, Charis A Marwick, Jo McEwen and 9 more

Abstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Eilidh M DuncanHealth Services Research Unit, University of Aberdeen, Aberdeen, Scotland, UK.
Esmita CharaniNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Faculty of Medicine, Imperial College London, London, UK.
Janet E ClarksonSchools of Dentistry, University of Dundee, Dundee, UK & University of Manchester, Manchester, UK, NHS Education for Scotland, Scotland.
Jill J FrancisSchool of Health Sciences, City University of London, London, UK.
Katie GilliesHealth Services Research Unit, University of Aberdeen, Aberdeen, Scotland, UK.
Jeremy M GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Winfried V KernUniversity of Freiburg Medical Center and Faculty of Medicine, Department of Medicine II/Infectious Diseases, Freiburg im Breisgau, Germany.
Fabiana LorencattoCentre for Behaviour Change, University College London, London, UK.
Charis A MarwickDivision of Population Health and Genomics, School of Medicine, University of Dundee, Scotland, UK.
Jo McEwenNinewells Hospital, Dundee, UK.
Ralph MöhlerDepartment of Health Services Research and Nursing Science, School of Public Health, Bielefeld University, Bielefeld, Germany.
Andrew M MorrisSinai Health System, University Health Network and University of Toronto, Toronto, Canada.
Craig R RamsayHealth Services Research Unit, University of Aberdeen, Aberdeen, Scotland, UK.
Susan Rogers Van KatwykSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Magdalena RzewuskaHealth Services Research Unit, University of Aberdeen, Aberdeen, Scotland, UK.
Brita SkodvinNorwegian Advisory Unit for Antibiotic Use in Hospitals, Haukeland University Hospital, Bergen, Norway.
Ingrid SmithDepartment of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.
Kathryn N SuhDepartment of Medicine, University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Peter G DaveyDivision of Population Health and Genomics, School of Medicine, University of Dundee, Scotland, UK.

Funding

Chief Scientist Office CZH/4/861Chief Scientist Office HSRU1Chief Scientist Office HSRU2Department of HealthWorld Health Organization 001
6 · The paper itself

Abstract

backgroundReducing unnecessary antibiotic exposure is a key strategy in reducing the development and selection of antibiotic-resistant bacteria. Hospital antimicrobial stewardship (AMS) interventions are inherently complex, often requiring multiple healthcare professionals to change multiple behaviours at multiple timepoints along the care pathway. Inaction can arise when roles and responsibilities are unclear. A behavioural perspective can offer insights to maximize the chances of successful implementation.

objectivesTo apply a behavioural framework [the Target Action Context Timing Actors (TACTA) framework] to existing evidence about hospital AMS interventions to specify which key behavioural aspects of interventions are detailed.

methodsRandomized controlled trials (RCTs) and interrupted time series (ITS) studies with a focus on reducing unnecessary exposure to antibiotics were identified from the most recent Cochrane review of interventions to improve hospital AMS. The TACTA framework was applied to published intervention reports to assess the extent to which key details were reported about what behaviour should be performed, who is responsible for doing it and when, where, how often and with whom it should be performed.

resultsThe included studies (n = 45; 31 RCTs and 14 ITS studies with 49 outcome measures) reported what should be done, where and to whom. However, key details were missing about who should act (45%) and when (22%). Specification of who should act was missing in 79% of 15 interventions to reduce duration of treatment in continuing-care wards.

conclusionsThe lack of precise specification within AMS interventions limits the generalizability and reproducibility of evidence, hampering efforts to implement AMS interventions in practice.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipHospitalsInterrupted Time Series AnalysisOutcome Assessment, Health CareAnti-Bacterial Agents

Identifiers

PMID32016346
PMCPMC7177472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.